Private hospitals directly procured over 1.27 crore Covid vaccine doses in May: Govt
In a written reply to a question in the Rajya Sabha, Minister of State for Health Bharati Pravin Pawar said a total of 83.61 lakh doses of the vaccines were administered at the private Covid vaccination centres (CVCs) from May to June 15. (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

NTAGI recommendation to increase gap between Covishield doses based on scientific evidence: Government
Responding to a question, Minister of State for Health Bharati Pravin Pawar said the COVID Working Group of NTAGI recommended extension of the gap between the first and second doses of Covishield vaccine to 12-16 weeks based on available scientific evidence particularly from the UK as well as WHO global guidance. (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

There are cases of people who have been COVID positive more than once: Govt tells Rajya Sabha
The study has concluded that while COVID-19 re-infection is still rarely reported, nonetheless, immunity should not be assumed and public health measures such as physical distancing, hand-hygiene and use of masks should be followed after recovery from first event of infection, Pawar said. (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

Covishield gives 93% protection against COVID, 98% mortality reduction, finds AFMC study
Addressing a press conference, NITI Aayog Member (Health) Dr V K Paul presented findings of the study which was conducted on 15 lakh doctors and frontline workers. (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

Expert panel recommends nod to SII for phase 2/3 trials of Covovax on children aged 2-17
"The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) deliberated on the revised study protocol application given by SII on Tuesday and recommended granting permission to the firm for conducting phase 2/3 trial of Covovax on children aged 2 to 17 years," a source said. (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

Covid-19: Government hopeful of vaccine for 12+ kids soon
Niti Aayog member (health) Dr VK Paul said, “We have visibility of 15 crore (150 million) doses for August. We will bring you the exact numbers at the next meeting but, as of now, we have visibility of 15 crore for next month.” (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

Margin performance in line with expectations: Jonathan Hunt, Syngene
"Given the second wave of the pandemic that we had in India, we have seen pretty strong sales on Remdesivir: the product that we manufacture under licence from Gilead. That, of course, gave an additional boost in the quarter." (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

Covid-19: Since May 1, private sector gave 7% of jabs despite 25% quota
TOI had reported on June 4 that private vaccination centres accounted for about 7.5% of vaccine doses administered since the beginning of the vaccination drive in January. The information given in Parliament shows that it remains at about the same level. (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

Covid-19: When will we reach herd immunity? Here are 3 reasons that's a hard question to answer
Different diseases have different thresholds for herd immunity. For measles, for example, the herd immunity threshold is 92%-94%. Estimates for COVID-19 have varied, with some putting it at 85% or higher. However, many hesitate to give a single number. Here are three reasons why. (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

New Covid-19 antibody treatment an interesting opportunity for Biocon: Kiran Mazumdar Shaw
"I personally believe that unless we have treatments that are effective, we are not in a safe place. That is where we are coming from and we believe this is a very interesting opportunity for Biocon because it really allows us to expand into adjacent areas." (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

Government directs private job portals to share job data of job seekers in the healthcare sector
After due deliberation, it has been decided that a dedicated window will be created on the National Career Service (NCS) portal of the ministry of labour and employment to match the demand for various categories of healthcare personnel and the available resources in a dynamic manner, the labour ministry said in an order dated July 26. (Source: The Economic Times)
Source: The Economic Times - July 27, 2021 Category: Consumer Health News Source Type: news

India must use, share Covid data transparently: Kiran Mazumdar-Shaw
Decrying the country ’s “lack of scientific temperament,” Kiran Mazumdar-Shaw urged greater transparency in sharing data on the pandemic, and said India has great potential to plan and respond to the virus based on such inputs. (Source: The Economic Times)
Source: The Economic Times - July 26, 2021 Category: Consumer Health News Source Type: news

65% sero positivity in Odisha enough to tide over third wave, say experts
The latest serological survey conducted in Ganjam, Rayagada and Koraput districts revealed a sero-positivity of more than 65% among the people. Experts said this sero prevalence is enough to reduce the impact of the third Covid wave, if any. (Source: The Economic Times)
Source: The Economic Times - July 25, 2021 Category: Consumer Health News Source Type: news

Cipla recalls 7,228 bottles of overactive bladder treatment drug in America
As per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. (Source: The Economic Times)
Source: The Economic Times - July 25, 2021 Category: Consumer Health News Source Type: news

Health ministry urges community radio stations to bust myths surrounding Covid vaccination
The thematic session highlighted the need to create meaningful awareness campaigns about Covid-appropriate behaviour and bust myths surrounding Covid vaccines and vaccination particularly among communities residing in remote and difficult to reach areas in the country. (Source: The Economic Times)
Source: The Economic Times - July 25, 2021 Category: Consumer Health News Source Type: news

Many now have immunity against COVID-19 but don't lower guard, say experts
Dr Yudhyavir Singh, who has been managing the COVID-19 ICU at AIIMS New Delhi, said it is important to lift a few restrictions to resume economic activities when cases are low. (Source: The Economic Times)
Source: The Economic Times - July 25, 2021 Category: Consumer Health News Source Type: news

73 pc rise in healthcare facilities in tribal areas between 2005 and 2020: Govt data
The number of sub health centres (SHC) in tribal areas increased by 78 per cent, from 16,748 in 2005 to 29,745 in 2020. (Source: The Economic Times)
Source: The Economic Times - July 25, 2021 Category: Consumer Health News Source Type: news

About 620 products see price reduction after trade margin regulation on critical medical devices
On July 13, the National Pharmaceuticals Pricing Authority (NPPA) had invoked extraordinary powers under the Paragraph 19 of DPCO, 2013, to put a cap on trade margin of five medical devices -- oximeter, glucometer, BP monitor, nebuliser and digital thermometer. (Source: The Economic Times)
Source: The Economic Times - July 24, 2021 Category: Consumer Health News Source Type: news

May need vaccine booster shots for emerging COVID variants: AIIMS Chief Dr Randeep Guleria
(Source: The Economic Times)
Source: The Economic Times - July 24, 2021 Category: Consumer Health News Source Type: news

COVID-19: Be watchful, next 3 months important, Niti Aayog's V K Paul tells Delhi govt
Dr Paul said that "unlock activity could lead to an increase in cases, though at present the positivity rate of cases is at its lowest point", according to the minutes of the meeting made public on July 20. (Source: The Economic Times)
Source: The Economic Times - July 23, 2021 Category: Consumer Health News Source Type: news

Doctor-population ratio 1:854, assuming 80% availability of allopathic doctors, 5.65 lakh AYUSH docs: Govt
In a written reply, Minister of State for Health Bharati Pravin Pawar also said that considering around 70 per cent availability of registered nursing personnel, the nurse-population ratio is 1:559. (Source: The Economic Times)
Source: The Economic Times - July 23, 2021 Category: Consumer Health News Source Type: news

Covid vaccines being used in country required to be stored within 2-8 Deg C temp range: Govt
In a written reply, the minister of state for health also said that there are 296 walk-in coolers and 57,640 ice-lined refrigerators in the country. (Source: The Economic Times)
Source: The Economic Times - July 23, 2021 Category: Consumer Health News Source Type: news

Virus will not mutate "dramatically" in the forthcoming months: Randeep Guleria on Covid 19
While a large section of the Indian population is scarred by the havoc caused during the second wave of COVID-19 a few months ago, many experts are claiming that the third wave of COVID-19 in the country is expected by August-end or by September., the third wave's arrival is a lot dependent on how we behave, said Dr Guleria. (Source: The Economic Times)
Source: The Economic Times - July 23, 2021 Category: Consumer Health News Source Type: news

Covid-19: ‘Virus will not mutate so dramatically in coming months’, says Randeep Guleria
(Source: The Economic Times)
Source: The Economic Times - July 23, 2021 Category: Consumer Health News Source Type: news

Approval given to use Coronil as supporting measure in Covid management: MoS Health
​​Minister of State for Health Bharati Pravin Pawar, in a written reply, said the Interdisciplinary Technical Review Committee (ITRC) setup by the AYUSH ministry reviewed the application submitted by the Patanjali Research Foundation Trust for "updating the AYUSH license for Divya Coronil tablet " from 'immunity booster' to 'medicine for COVID-19'. (Source: The Economic Times)
Source: The Economic Times - July 23, 2021 Category: Consumer Health News Source Type: news

Covid-19: India reports 35,342 new cases, 483 fatalities in last 24 hours
(Source: The Economic Times)
Source: The Economic Times - July 23, 2021 Category: Consumer Health News Source Type: news

What's worse than a pandemic? A twindemic
One reason to get more serious about flu is its cost, both economically and in human terms. Annual costs of treating influenza (routinely in excess of $10 billion in the U.S.) are significant, even when you just look at hospital outlays for those most severely affected. (Source: The Economic Times)
Source: The Economic Times - July 23, 2021 Category: Consumer Health News Source Type: news

BPaL regimen can cut time for treatment of drug-resistant TB
BPaL is a six-month, alloral, three-drug regimen that is used to treat people with highly drug-resistant forms of TB. It consists of the TB Alliance developed antibiotic pretomanid, along with two other antibiotics: bedaquiline and linezolid. (Source: The Economic Times)
Source: The Economic Times - July 22, 2021 Category: Consumer Health News Source Type: news

Study finds lower antibody activity against delta variant at single dose, but vaccines still work
This virus has spread to at least 90 countries and is 50% more transmissible than the alpha variant (the variant first identified in Kent), which is around 50% more transmissible than the original coronavirus that caused the pandemic. (Source: The Economic Times)
Source: The Economic Times - July 22, 2021 Category: Consumer Health News Source Type: news

Dubai - The Next Healthcare And Pharma Hub
(Source: The Economic Times)
Source: The Economic Times - July 22, 2021 Category: Consumer Health News Source Type: news

Over 95 lakh Covid vaccine doses administered in Delhi till now: Bulletin
The national capital received 85,810 doses of Covishield on Tuesday, taking the total number of doses available in Delhi to 1,08,300. The total number of Covaxin doses available stands at 1,84,390. Only 20 per cent of Covaxin stock can be used for the first dose, since its stock is limited and has irregular delivery cycles (Source: The Economic Times)
Source: The Economic Times - July 21, 2021 Category: Consumer Health News Source Type: news

Linear correlation between meditation & organisational productivity: A session with Daaji & ETILC members
For business leaders, contemplative heartfulness meditation that is aided with transmission of pranahuti is recommended before work. (Source: The Economic Times)
Source: The Economic Times - July 21, 2021 Category: Consumer Health News Source Type: news

P681R mutation in Delta key to severity, say new studies
The P681R mutation, which is said to drive syncytium formation - fusing of infected lung cells - associated with severe forms of SARS-COV-2, or Covid-19. (Source: The Economic Times)
Source: The Economic Times - July 21, 2021 Category: Consumer Health News Source Type: news

Shocking, disrespectful to the dead: Policy expert takes on govt claim of zero oxygen-related Covid deaths
"This statement comes at a time when Parliament should have seriously been discussing the lessons from that experience. People were struggling to get beds, people were struggling for simple supplies like oxygen. Just look at how senior doctors lost their lives because hospitals ran out of oxygen." (Source: The Economic Times)
Source: The Economic Times - July 21, 2021 Category: Consumer Health News Source Type: news

Two-thirds of Indians over six have COVID antibodies, 40 crore still at risk: ICMR sero-survey
(Source: The Economic Times)
Source: The Economic Times - July 21, 2021 Category: Consumer Health News Source Type: news

Human-to-human transmission of bird flu rare, no need to panic: AIIMS chief Dr Randeep Guleria
"The transmission of the virus from birds to humans is rare and sustained human-to-human transmission of the H5N1 virus has not yet been established and therefore there is no need to panic. But then people working closely with poultry must take precautionary measures and maintain proper personal hygiene," Dr Guleria said. (Source: The Economic Times)
Source: The Economic Times - July 21, 2021 Category: Consumer Health News Source Type: news

Would be wise to open primary schools before secondary ones: ICMR DG
(Source: The Economic Times)
Source: The Economic Times - July 20, 2021 Category: Consumer Health News Source Type: news

Azithromycin no more effective against COVID-19 than placebo: Study
The research, published in the Journal of the American Medical Association, included 263 participants who all tested positive for SARS-CoV-2, the virus which causes COVID-19, within seven days before entering the study. (Source: The Economic Times)
Source: The Economic Times - July 19, 2021 Category: Consumer Health News Source Type: news

Covid antibodies last at least nine months after infection, study finds
Researchers from the University of Padua in Italy and Imperial College London in the UK tested over 85 per cent of the 3,000 residents of Vo', Italy, in February and March last year for infection with SARS-CoV-2, the virus that causes COVID-19. (Source: The Economic Times)
Source: The Economic Times - July 19, 2021 Category: Consumer Health News Source Type: news

Bharat Biotech dossier under review for Covaxin emergency use listing: WHO
Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said urged people to act 'urgently' to contain the spread of the COVID-19 virus and aggressively scale up vaccination especially of the vulnerable population for containment of the possible third wave. (Source: The Economic Times)
Source: The Economic Times - July 19, 2021 Category: Consumer Health News Source Type: news

Seeds of Innocence to add 20 IVF & fertility centres across India by FY22
During this month, Seeds of Innocence (SOI) will be launching IVF centres in Guwahati (Assam) and Haldwani (Uttarakhand). The centre in Guwahati will also mark the first venture of the company in the eastern part of the country, Seeds of Innocence& Genestrings Founder Gauri Agarwal told . (Source: The Economic Times)
Source: The Economic Times - July 18, 2021 Category: Consumer Health News Source Type: news

Health ministry advises TB Screening for all Covid patients and vice versa
(Source: The Economic Times)
Source: The Economic Times - July 17, 2021 Category: Consumer Health News Source Type: news

COVID vaccine: DCGI examining Zydus Cadila's 'ZyCoV-D' for children, says Dr VK Paul
(Source: The Economic Times)
Source: The Economic Times - July 17, 2021 Category: Consumer Health News Source Type: news

India records greatest increase in number of children not receiving first dose of DTP-1 vaccine in 2020: UN
Data from the World Health Organisation (WHO) and the UN children's agency UNICEF showed that 23 million children missed out on basic childhood vaccines through routine health services in 2020, the highest number since 2009 and 3.7 million more than in 2019. (Source: The Economic Times)
Source: The Economic Times - July 17, 2021 Category: Consumer Health News Source Type: news

Vaccine offers 99% protection against death in Delta strain, finds NIV study
The genomic analysis carried out as part of the study showed the Delta variant ’s presence in the majority of the samples, but there also were other variants such as Alpha, Kappa, Delta AY.1 (known as the Delta-plus variant in samples from MP and Rajasthan) and Delta AY.2. (Source: The Economic Times)
Source: The Economic Times - July 17, 2021 Category: Consumer Health News Source Type: news

Bharat Biotech's partner Ocugen seeks approval for Covaxin in Canada
The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, it said on Thursday. (Source: The Economic Times)
Source: The Economic Times - July 16, 2021 Category: Consumer Health News Source Type: news

Majority of Covid cases after immunisation is due to Delta variant: ICMR Study
This study indicated that the majority of the clinical cases in the breakthrough were infected with the Delta variant and only 9.8 per cent cases required hospitalization while fatality was observed in only 0.4 per cent cases. Breakthrough infection is if one gets infected even after immunisation. (Source: The Economic Times)
Source: The Economic Times - July 16, 2021 Category: Consumer Health News Source Type: news

Clinical trial for Covid vaccines for children on verge of completion: Centre to Delhi HC
A policy will be formed by the government and children will be vaccinated when experts give permission, the Centre said. (Source: The Economic Times)
Source: The Economic Times - July 16, 2021 Category: Consumer Health News Source Type: news

Don't let your guard down: Vaccinated people not safe from coronavirus' Delta variant
(Source: The Economic Times)
Source: The Economic Times - July 16, 2021 Category: Consumer Health News Source Type: news

2 doses of vaccine successful in preventing 95% of Covid deaths: Dr VK Paul
(Source: The Economic Times)
Source: The Economic Times - July 16, 2021 Category: Consumer Health News Source Type: news